Institut Catala dOncologia Badalona

Badalona 08916

2 studies enrolling now · 3 studies all time

What they study most

Advanced Non-Small Cell Lung Cancer, Endometrial Cancer, Head and Neck Cancer, Low-grade Serous Ovarian Cancer, Metastatic Non-Small Cell Lung Cancer, Recurrent Endometrial Cancer, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Cancer, Recurrent Primary Peritoneal Cancer

Studies at this site

• Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7 — Recruiting now
• Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers — Recruiting now
• The BURAN Study of Buparlisib in Patients With Recurrent or Metastatic HNSCC — Completed